High Granular Tick Data API: US Stocks Learn more

Arcturus Therapeutics Holdings Inc icon

Arcturus Therapeutics Holdings Inc (ARCT NASDAQ) stock market data APIs

$8.6797 0.04(0.5%)
as of April 15, 2026
Try our APIs with free plan!

Arcturus Therapeutics Holdings Inc Financial Data Overview

Price chart is built with Anychart

Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a self-amplifying mRNA technology platform, and LUNAR, a lipid-mediated delivery system. The company also develops ARCT-032 (LUNAR-CF), an mRNA therapeutic candidate for cystic fibrosis that is in Phase 2 clinical development; and ARCT-810 (LUNAR-OTC), which is in Phase 2 clinical development to address ornithine transcarbamylase (OTC) deficiency. In addition, it develops KOSTAIVE, a self-amplifying RNA vaccine for COVID-19; ARCT-2138 (LUNAR-FLU), which is in Phase1 clinical trial for the treatment of seasonal influenza; and ARCT-2304 (LUNAR-H5N1) that is in Phase1 clinical trial for the treatment of Pandemic Influenza. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.

Prev. Close 8.6797
Open 8.7227
High 8.8657
Low 8.5951
52 wk Range 5.85-24.17
Market Cap 247 M
Shares Outstanding 28 423 K
Revenue 82 031 K
EPS -1.03
Beta 2.436

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


ETFs with Arcturus Therapeutics Holdings Inc (top by weight)

Ticker
100-day Price Change
Weight
ARKG.US ARK Genomic Revolution ETF
-0.04 (-0.13%)
2.06
WDNA.US WisdomTree BioRevolution Fund
1.5 (8.82%)
0.90
NXTE.US Investment Managers Series Trust II - AXS Sustainable Alpha ETF
3.13 (7.71%)
0.29
GNOM.US Global X Genomics & Biotechnology ETF
1 (2.18%)
0.27

* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Arcturus Therapeutics Holdings Inc data using free add-ons & libraries


Get Arcturus Therapeutics Holdings Inc Fundamental Data

Arcturus Therapeutics Holdings Inc logo

Arcturus Therapeutics Holdings Inc Fundamental data includes:

  • Net Revenue: 82 031 K
  • EBITDA: -73 235 000
  • Earnings Per Share:
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Arcturus Therapeutics Holdings Inc Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2026-03-02
  • EPS/Forecast: 4.28
GET THE PACKAGE

Get Arcturus Therapeutics Holdings Inc End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

Arcturus Therapeutics Holdings Inc News

Get Arcturus Therapeutics Holdings Inc fresh news feed via Financial News API

Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat

Send the request

Leave your email and our team will contact you ASAP.